De novo food allergy in pediatric liver transplantation recipients

Ratchaneewan Sinitkul1, Wiparat Manuyakorn1, Wasu Kamchaisatian1

  • 1Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Insights

Food allergy (FA) is common after pediatric liver transplants (LT), affecting over half of recipients. Younger age at transplant, family history of atopy, and Epstein-Barr virus (EBV) viremia increase FA risk.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Immunology
  • Allergy and Immunology

Background:

  • The prevalence of food allergy (FA) is rising in children who have undergone liver transplantation (LT).
  • Limited data exists on the clinical course and outcomes of de novo FA post-LT.

Purpose of the Study:

  • To determine the prevalence of de novo food allergy in pediatric liver transplant recipients.
  • To identify risk factors associated with developing de novo FA post-LT.
  • To describe the natural history of de novo FA in this population.

Main Methods:

  • Retrospective cohort study of pediatric LT recipients (Jan 2001 - Dec 2014).
  • De novo FA diagnosed by post-LT symptoms, improvement with elimination diets, and confirmed by re-challenge, sensitization, or eosinophilia.
  • Analysis of medical records to identify risk factors and clinical characteristics.

Main Results:

  • Over half (54.3%) of 46 pediatric LT recipients developed de novo FA at a median of 12.2 months post-transplant.
  • Confirmed FA occurred in 39.1%, with gastrointestinal symptoms being most common, followed by skin reactions and anaphylaxis.
  • Risk factors included age <2 years at LT (HR 2.62), family history of atopy (HR 5.67), and Epstein-Barr virus (EBV) viremia (HR 2.39).

Conclusions:

  • De novo food allergy is a significant concern in pediatric liver transplant recipients.
  • Early age at transplant (<2 years), family history of atopy, and EBV viremia are key risk factors for developing FA.
  • Tolerance development over 3 years appears similar to the general population.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
26
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
487
Allergic Reactions02:06

Allergic Reactions

Overview
32.6K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
25
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
534
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
32